DOCSLIB.ORG

The Alkaline Phosphatase (ALPL) Locus Is Associated with B6 Vitamer Levels in CSF and Plasma

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Alkaline Phosphatase (ALPL) Locus Is Associated with B6 Vitamer Levels in CSF and Plasma G C A T T A C G G C A T genes Article The Alkaline Phosphatase (ALPL) Locus Is Associated with B6 Vitamer Levels in CSF and Plasma Loes M. Olde Loohuis 1,† , Monique Albersen 2,†,‡, Simone de Jong 1, Timothy Wu 1 , Jurjen J. Luykx 3,4 , Judith J. M. Jans 2, Nanda M. Verhoeven-Duif 2 and Roel A. Ophoff 1,* 1 Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles (UCLA), Los Angeles, CA 90095, USA; [email protected] (L.M.O.L.); [email protected] (S.d.J.); [email protected] (T.W.) 2 Section Metabolic Diagnostics, Department of Genetics, University Medical Center (UMC), 3584 EA Utrecht, The Netherlands; [email protected] (M.A.); [email protected] (J.J.M.J.); [email protected] (N.M.V.-D.) 3 Department of Psychiatry, Rudolf Magnus Institute of Neuroscience, University Medical Center (UMC), 3584 CG Utrecht, The Netherlands; [email protected] 4 Department of Translational Neuroscience, Human Neurogenetics Unit, Brain Center Rudolf Magnus, University Medical Center Utrecht (UMC), 3584 CG Utrecht, The Netherlands * Correspondence: [email protected] † These authors contributed equally to this work. ‡ Present address: Amsterdam UMC, VU Medical Center, Department of Clinical Chemistry, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands. Received: 3 December 2018; Accepted: 14 December 2018; Published: 22 December 2018 Abstract: The active form of vitamin B6, pyridoxal phosphate (PLP), is essential for human metabolism. The brain is dependent on vitamin B6 for its neurotransmitter balance. To obtain insight into the genetic determinants of vitamin B6 homeostasis, we conducted a genome-wide association study (GWAS) of the B6 vitamers pyridoxal (PL), PLP and the degradation product of vitamin B6, pyridoxic acid (PA). We collected a unique sample set of cerebrospinal fluid (CSF) and plasma from the same healthy human subjects of Dutch ancestry (n = 493) and included concentrations and ratios in and between these body fluids in our analysis. Based on a multivariate joint analysis of all B6 vitamers and their ratios, we identified a genome-wide significant association at a locus on chromosome 1 containing the ALPL (alkaline phosphatase) gene (minimal p = 7.89 × 10−10, rs1106357, minor allele frequency (MAF) = 0.46), previously associated with vitamin B6 levels in blood. Subjects homozygous for the minor allele showed a 1.4-times-higher ratio between PLP and PL in plasma, and even a 1.6-times-higher ratio between PLP and PL in CSF than subjects homozygous for the major allele. In addition, we observed a suggestive association with the CSF:plasma ratio of PLP on chromosome 15 (minimal p = 7.93 × 10−7, and MAF = 0.06 for rs28789220). Even though this finding is not reaching genome-wide significance, it highlights the potential of our experimental setup for studying transport and metabolism across the blood–CSF barrier. This GWAS of B6 vitamers identifies alkaline phosphatase as a key regulator in human vitamin B6 metabolism in CSF as well as plasma. Furthermore, our results demonstrate the potential of genetic studies of metabolites in plasma and CSF to elucidate biological aspects underlying metabolite generation, transport and degradation. Keywords: genome wide association study; vitamin B6; cerebrospinal fluid; plasma 1. Introduction The active form of vitamin B6, pyridoxal phosphate (PLP), functions as a co-factor in >200 enzymatic reactions in human metabolism [1,2]. Inverse relationships have been found between Genes 2019, 10, 8; doi:10.3390/genes10010008 www.mdpi.com/journal/genes Genes 2018, 9 FOR PEER REVIEW 2 of 14 1. Introduction The active form of vitamin B6, pyridoxal phosphate (PLP), functions as a co-factor in >200 Genes 2019, 10, 8 2 of 14 enzymatic reactions in human metabolism [1,2]. Inverse relationships have been found between vitamin B6 and conditions such as diabetes, oxidative stress, cardiovascular disease, inflammation vitaminand cancer B6 and [3–7]. conditions Its role such in amino as diabetes, acid oxidativeand neurotransmitter stress, cardiovascular metabolism disease, renders inflammation vitamin and B6 cancerspecifically [3–7]. essential Its role infor amino brain aciddevelopment and neurotransmitter and functioning. metabolism Lower concentrations renders vitamin of PLP B6 specifically in plasma essentialhave not foronly brain been development associated with and functioning.symptoms of Lower depression concentrations (according of to PLP the in Major plasma Depression have not onlyInventory been associated[8]), but also with with symptoms poor cognition of depression [9] and (according Alzheimer’s to thedisease Major [10,11]. Depression Inventory [8]), but alsoThe with dependence poor cognition of the [neurotransmitter9] and Alzheimer’s balance disease in [ 10the,11 brain]. on vitamin B6 is illustrated by inbornThe errors dependence of metabolism of the neurotransmitter resulting in hampered balance in thevitamin brain onB6 vitaminmetabolism. B6 is illustratedSuch patients by inborn may errorspresent of with metabolism epilepsy resulting and intellectual in hampered disability vitamin [12]. B6 metabolism. Examples Suchof these patients genetic may disorders present with are epilepsyantiquitin and deficiency intellectual (OMIM disability #266100) [12]. [13], Examples pyridox(am)ine-5 of these genetic′-phosphate disorders oxidase are antiquitin (PNPO) deficiencydeficiency (OMIM(OMIM #266100)#610090) [[14],13], pyridox(am)ine-5hyperprolinaemia0-phosphate type II (pyrroline-5-carboxylate oxidase (PNPO) deficiency dehydrogenase (OMIM #610090) deficiency; [14], hyperprolinaemiaOMIM #239510) [15] type and II (pyrroline-5-carboxylate hypophosphatasia (alk dehydrogenasealine phosphatase deficiency; (ALPL) OMIM deficiency; #239510) OMIM [15] and#241500) hypophosphatasia [16,17]. Although (alkaline in phosphataseantiquitin and (ALPL) PNPO deficiency; deficiencies, OMIM treatment #241500) with [16,17 vitamin]. Although B6 inis antiquitinsuccessful andin antagonizing PNPO deficiencies, the epilepsy, treatment patients with with vitamin these B6 inborn is successful metabolic in antagonizing disorders will the still epilepsy, suffer patientsfrom intellectual with these disability inborn metabolic [12,18]. In disorders addition will to stillthese suffer known from causes intellectual of functional disability vitamin [12,18]. B6 In additiondeficiency, to there these knownare patients causes in ofwhom functional the caus vitamine of their B6 deficiency, vitamin B6-responsive there are patients epilepsy in whom remains the causeunelucidated. of their vitamin B6-responsive epilepsy remains unelucidated. Humans depend depend on on dietary dietary sources sources of ofvitamin vitamin B6 since B6 since they theyare unable are unable to synthesize to synthesize it. The it.different The differentB6 vitamers—pyridoxine B6 vitamers—pyridoxine (PN), pyridoxami (PN), pyridoxaminene (PM), pyridoxal (PM), pyridoxal(PL) and their (PL) respective and their respectivephosphate-esters phosphate-esters (Figure 1)—are (Figure interconvertible1)—are interconvertible through the through action theof several action ofenzymes. several enzymes.Transport Transportacross the acrosscell membrane the cell membrane is preceded is by preceded hydrolysis by hydrolysisof the phosphorylated of the phosphorylated B6 vitamers B6by vitamersmembrane- by membrane-boundbound alkaline phosphatase alkaline phosphatase (ALPL) [19]. (ALPL) The ALPL [19]. locus The ALPLhas been locus associated has been with associated PLP and with vitamin PLP andB6 in vitamin plasma B6 [20–23]. in plasma Intracellularly, [20–23]. Intracellularly, phosphorylat phosphorylationion by pyridoxal by kinase pyridoxal (PDXK) kinase [24] (PDXK)yields PNP, [24] yieldsPMP and PNP, PLP PMP (Figure and PLP1). Pyridox(am)ine (Figure1). Pyridox(am)ine phosphate oxidase phosphate converts oxidase PNP converts and PMP PNP into andthe active PMP intoco-factor, the active PLP co-factor,[25]. Release PLP of [25 vitamin]. Release B6 offrom vitamin the cell B6 fromis dependent the cell is on dependent a vitamin on B6-specific a vitamin B6-specificphosphatase phosphatase (pyridoxal phosphatase (pyridoxal phosphatase(PDXP)) [26]. (PDXP))Oxidation [26 of]. the Oxidation resulting PL of by the aldehyde resulting oxidase PL by aldehyde(AOX) [27] oxidase constitutes (AOX) the [ 27degradation] constitutes pathway the degradation of vitamin pathway B6, of which of vitamin the major B6, ofproduct, which thepyridoxic major product,acid (PA), pyridoxic is excreted acid into (PA), urine is excreted (Figure into 1) urine [28]. (FigureAlthough1)[ 28the]. Althoughenzymes theinvolved enzymes in involvedvitamin B6 in vitaminmetabolism B6 metabolism have been elucidated have been at elucidated genetic and at genetic protein and levels, protein knowledge levels, knowledgeabout human about vitamin human B6 vitamintransport B6 is transport very limited. is very At limited.the biochemical At the biochemical level, there level, is evidence there is for evidence carrier-mediated for carrier-mediated transport transport[29–31], but [29 not–31 ],a single but not human a single vitamin human B6 vitamin transporter B6 transporter has been identified has been identified to date. to date. Figure 1.1. Schematic display of vitamin B6 metabolism.metabolism. The different B6 vitamers pyridoxine (PN), pyridoxaminepyridoxamine (PM), pyridoxal (PL) and their respective phosphate-estersphosphate-esters (PNP, PMP and PLP) are interconvertibleinterconvertible
Load more

Recommended publications
  • Evaluation of Potential Biomarkers for Ewing´S Sarcoma As Cargo of Tumor Derived Exosomes
    TECHNISCHE UNIVERSITÄT MÜNCHEN Klinik und Poliklinik für Kinder- und Jugendmedizin Klinikum rechts der Isar Direktor: Univ.-Prof. Dr. St. Burdach Evaluation of potential biomarkers for Ewing´s sarcoma as cargo of tumor derived exosomes Isabella Viktoria Miller Vollständiger Abdruck der von der Fakultät für Medizin der Technischen Universität München zur Erlangung des akademischen Grades eines Doktors der Medizin genehmigten Dissertation. Vorsitzender: Univ.-Prof. Dr. E. J. Rummeny Prüfer der Dissertation: 1. Univ.-Prof. Dr. St. Burdach 2. Priv.-Doz. Dr. J. M. E. Teichert-von Lüttichau 3. Univ.-Prof. Dr. A. Krackhardt Die Dissertation wurde am 31.10.2014 bei der Technischen Universität München eingereicht und durch die Fakultät für Medizin am 03.02.2016 angenommen. Contents List of Abbreviations 6 Summary 8 1 Introduction 9 1.1 Ewing´s sarcoma . .9 1.1.1 The Ewing family of tumors . .9 1.1.2 RNA based markers for subclinical disease and their limitations . 10 1.2 Exosomes . 11 1.2.1 Biogenesis and classification . 11 1.2.2 Communication pathways . 12 1.2.3 Roles in tumorigenesis . 14 1.2.3.1 Immunosuppression . 15 1.2.3.2 Angiogenesis . 15 1.2.3.3 Modulation of the microenvironment . 15 1.2.3.4 Metastasis . 16 1.2.3.5 Drug resistance . 17 1.2.4 Diagnostic implications as tumor markers . 17 1.3 Research objectives . 24 1.3.1 Aim of the project . 24 1.3.2 Key questions . 24 2 Materials and Methods 25 2.1 Materials . 25 2.1.1 List of Manufacturers . 25 2.1.2 General materials .
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • ATA33632-NBPF3 Rabbit Polyclonal Antibody
    ATAGENIX LABORATORIES Catalog Number:ATA33632 NBPF3 rabbit Polyclonal Antibody Product overview product name NBPF3 rabbit Polyclonal Antibody catalog No. ATA33632 Category Primary antibodies Host Rabbit Species specificity Human Tested applications WB,ELISA Clonality Polyclonal Conjugation Unconjugated Immunogen Synthesized peptide derived from human protein . at AA range: 410-490 Product performance Form Liquid Storage Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 °C for frequent use. Store at -20 to -80 °C for twelve months from the date of receipt. Purity The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. Dilution range WB 1:500-2000 ELISA 1:5000-20000 Product background neuroblastoma breakpoint family member 3(NBPF3) Homo sapiens This gene is a member of the neuroblastoma breakpoint family (NBPF) which consists of dozens of recently duplicated genes primarily located in segmental duplications on human chromosome 1. This gene family has experienced its greatest expansion within the human lineage and has expanded, to a lesser extent, among primates in general. Members of this gene family are characterized by tandemly repeated copies of DUF1220 protein domains. DUF1220 copy number variations in human chromosomal region 1q21.1, where most DUF1220 domains are located, have been implicated in a number of developmental and neurogenetic diseases such as microcephaly, macrocephaly, autism, schizophrenia, mental retardation, congenital heart disease, neuroblastoma, and congenital kidney and urinary tract anomalies. Altered expression of some gene family members is associated with several types of cancer. This gene fami Web:www.atagenix.com E-mail: [email protected] Tel: 027-87433958.
    [Show full text]
  • Variation in Protein Coding Genes Identifies Information
    bioRxiv preprint doi: https://doi.org/10.1101/679456; this version posted June 21, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Animal complexity and information flow 1 1 2 3 4 5 Variation in protein coding genes identifies information flow as a contributor to 6 animal complexity 7 8 Jack Dean, Daniela Lopes Cardoso and Colin Sharpe* 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 Institute of Biological and Biomedical Sciences 25 School of Biological Science 26 University of Portsmouth, 27 Portsmouth, UK 28 PO16 7YH 29 30 * Author for correspondence 31 [email protected] 32 33 Orcid numbers: 34 DLC: 0000-0003-2683-1745 35 CS: 0000-0002-5022-0840 36 37 38 39 40 41 42 43 44 45 46 47 48 49 Abstract bioRxiv preprint doi: https://doi.org/10.1101/679456; this version posted June 21, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Animal complexity and information flow 2 1 Across the metazoans there is a trend towards greater organismal complexity. How 2 complexity is generated, however, is uncertain. Since C.elegans and humans have 3 approximately the same number of genes, the explanation will depend on how genes are 4 used, rather than their absolute number.
    [Show full text]
  • Genome-Wide Mega-Analysis Identifies 16 Loci and Highlights Diverse Biological Mechanisms in the Common Epilepsies." (2018)
    Follow this and additional works at: https://jdc.jefferson.edu/neurologyfp Part of the Neurology Commons Let us know how access to this document benefits ouy Recommended Citation Abou-Khalil, Bassel; Auce, Pauls; Avbersek, Andreja; Bahlo, Melanie; ThomasBalding, JeffDaviderson J.; Bast, Univ ersity Thomas; Baum, Larry; Becker, Albert J.; Becker, Felicitas;Jeff Berghuis,erson Bianca; Digital Berkovic, Commons Samuel F.; Boysen, Katja E.; Bradfield, Jonathan .;P Brody, Lawrence C.; Buono, Russell J.; Campbell, Ellen; Cascino, Gregory D.; Catarino, Claudia B.; Cavalleri, Gianpiero L.; Cherny, Stacey S.; Chinthapalli, Krishna;Department Coff ofey Neur, Alisonology J.; CompstFaculty Pon,apers Alastair; Coppola, Antonietta; Cossette,Depar Ptmentatrick; of Cr Neuraig, ologyJohn J.; de Haan, Gerrit-Jan; De Jonghe, Peter; de Kovel, Carolien G.F.; Delanty, Norman; Depondt, 12-10-2018Chantal; De vinsky, Orrin; Dlugos, Dennis J.; Doherty, Colin P.; Elger, Christian E.; Eriksson, Johan G.; Ferraro, Thomas N.; Feuch, Martha; Francis, Ben; Franke, Andre; French, Jacqueline A.; Genome-wideFreytag, Saskia; Gaus, mega-analysis Verena; Geller, Eric B.; identifies Gieger, Christian; 16 Glauserloci and, Tracy; highlights Glynn, Simon; Goldstein, David B.; Gui, Hongsheng; Guo, Youling; Haas, Kevin F.; Hakonarson, Hakon; Hallmann, Kdiverstin;erse Haut, biological Sheryl; Heinz mechanismsen, Erin L.; Helbig, Ingo; in the Hengsbach, common Christian; epilepsies. Hjalgrim, Helle; BasselIacomino, Abou-Khalil Michele; Ingason, Andrés; Jamnadas-Khoda, Jennifer; Johnson,
    [Show full text]
  • Identification of Potential Key Genes and Pathway Linked with Sporadic Creutzfeldt-Jakob Disease Based on Integrated Bioinformatics Analyses
    medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Identification of potential key genes and pathway linked with sporadic Creutzfeldt-Jakob disease based on integrated bioinformatics analyses Basavaraj Vastrad1, Chanabasayya Vastrad*2 , Iranna Kotturshetti 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. 3. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka 562209, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Abstract Sporadic Creutzfeldt-Jakob disease (sCJD) is neurodegenerative disease also called prion disease linked with poor prognosis. The aim of the current study was to illuminate the underlying molecular mechanisms of sCJD. The mRNA microarray dataset GSE124571 was downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were screened.
    [Show full text]
  • Overexpressed Somatic Alleles Are Enriched in Functional Elements in Breast Cancer
    University of Massachusetts Medical School eScholarship@UMMS Open Access Articles Open Access Publications by UMMS Authors 2017-08-15 Overexpressed somatic alleles are enriched in functional elements in Breast Cancer Paula Restrepo George Washington University Et al. Let us know how access to this document benefits ou.y Follow this and additional works at: https://escholarship.umassmed.edu/oapubs Part of the Cancer Biology Commons, Genetic Phenomena Commons, Genetics and Genomics Commons, and the Neoplasms Commons Repository Citation Restrepo P, Movassagh M, Alomran N, Miller C, Li M, Trenkov C, Manchev Y, Bahl S, Warnken S, Spurr L, Apanasovich T, Crandall K, Edwards N, Horvath A. (2017). Overexpressed somatic alleles are enriched in functional elements in Breast Cancer. Open Access Articles. https://doi.org/10.1038/ s41598-017-08416-w. Retrieved from https://escholarship.umassmed.edu/oapubs/3243 Creative Commons License This work is licensed under a Creative Commons Attribution 4.0 License. This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Open Access Articles by an authorized administrator of eScholarship@UMMS. For more information, please contact [email protected]. www.nature.com/scientificreports OPEN Overexpressed somatic alleles are enriched in functional elements in Breast Cancer Received: 1 March 2017 Paula Restrepo1,2, Mercedeh Movassagh3, Nawaf Alomran2,4, Christian Miller2, Muzi Li2,4, Accepted: 10 July 2017 Chris Trenkov2, Yulian Manchev2, Sonali Bahl1, Stephanie Warnken 5, Liam Spurr1,2, Tatiyana Published: xx xx xxxx Apanasovich6, Keith Crandall 5, Nathan Edwards4 & Anelia Horvath 1,2,6,7 Asymmetric allele content in the transcriptome can be indicative of functional and selective features of the underlying genetic variants.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 9,689,046 B2 Mayall Et Al
    USOO9689046B2 (12) United States Patent (10) Patent No.: US 9,689,046 B2 Mayall et al. (45) Date of Patent: Jun. 27, 2017 (54) SYSTEM AND METHODS FOR THE FOREIGN PATENT DOCUMENTS DETECTION OF MULTIPLE CHEMICAL WO O125472 A1 4/2001 COMPOUNDS WO O169245 A2 9, 2001 (71) Applicants: Robert Matthew Mayall, Calgary (CA); Emily Candice Hicks, Calgary OTHER PUBLICATIONS (CA); Margaret Mary-Flora Bebeselea, A. et al., “Electrochemical Degradation and Determina Renaud-Young, Calgary (CA); David tion of 4-Nitrophenol Using Multiple Pulsed Amperometry at Christopher Lloyd, Calgary (CA); Lisa Graphite Based Electrodes', Chem. Bull. “Politehnica” Univ. Kara Oberding, Calgary (CA); Iain (Timisoara), vol. 53(67), 1-2, 2008. Fraser Scotney George, Calgary (CA) Ben-Yoav. H. et al., “A whole cell electrochemical biosensor for water genotoxicity bio-detection”. Electrochimica Acta, 2009, 54(25), 6113-6118. (72) Inventors: Robert Matthew Mayall, Calgary Biran, I. et al., “On-line monitoring of gene expression'. Microbi (CA); Emily Candice Hicks, Calgary ology (Reading, England), 1999, 145 (Pt 8), 2129-2133. (CA); Margaret Mary-Flora Da Silva, P.S. et al., “Electrochemical Behavior of Hydroquinone Renaud-Young, Calgary (CA); David and Catechol at a Silsesquioxane-Modified Carbon Paste Elec trode'. J. Braz. Chem. Soc., vol. 24, No. 4, 695-699, 2013. Christopher Lloyd, Calgary (CA); Lisa Enache, T. A. & Oliveira-Brett, A. M., "Phenol and Para-Substituted Kara Oberding, Calgary (CA); Iain Phenols Electrochemical Oxidation Pathways”, Journal of Fraser Scotney George, Calgary (CA) Electroanalytical Chemistry, 2011, 1-35. Etesami, M. et al., “Electrooxidation of hydroquinone on simply prepared Au-Pt bimetallic nanoparticles'. Science China, Chem (73) Assignee: FREDSENSE TECHNOLOGIES istry, vol.
    [Show full text]
  • Paraneoplastic Neurological and Muscular Syndromes
    Paraneoplastic neurological and muscular syndromes Short compendium Version 4.5, April 2016 By Finn E. Somnier, M.D., D.Sc. (Med.), copyright ® Department of Autoimmunology and Biomarkers, Statens Serum Institut, Copenhagen, Denmark 30/01/2016, Copyright, Finn E. Somnier, MD., D.S. (Med.) Table of contents PARANEOPLASTIC NEUROLOGICAL SYNDROMES .................................................... 4 DEFINITION, SPECIAL FEATURES, IMMUNE MECHANISMS ................................................................ 4 SHORT INTRODUCTION TO THE IMMUNE SYSTEM .................................................. 7 DIAGNOSTIC STRATEGY ..................................................................................................... 12 THERAPEUTIC CONSIDERATIONS .................................................................................. 18 SYNDROMES OF THE CENTRAL NERVOUS SYSTEM ................................................ 22 MORVAN’S FIBRILLARY CHOREA ................................................................................................ 22 PARANEOPLASTIC CEREBELLAR DEGENERATION (PCD) ...................................................... 24 Anti-Hu syndrome .................................................................................................................. 25 Anti-Yo syndrome ................................................................................................................... 26 Anti-CV2 / CRMP5 syndrome ............................................................................................
    [Show full text]
  • Downloaded from the App Store and Nucleobase, Nucleotide and Nucleic Acid Metabolism 7 Google Play
    Hoytema van Konijnenburg et al. Orphanet J Rare Dis (2021) 16:170 https://doi.org/10.1186/s13023-021-01727-2 REVIEW Open Access Treatable inherited metabolic disorders causing intellectual disability: 2021 review and digital app Eva M. M. Hoytema van Konijnenburg1†, Saskia B. Wortmann2,3,4†, Marina J. Koelewijn2, Laura A. Tseng1,4, Roderick Houben6, Sylvia Stöckler‑Ipsiroglu5, Carlos R. Ferreira7 and Clara D. M. van Karnebeek1,2,4,8* Abstract Background: The Treatable ID App was created in 2012 as digital tool to improve early recognition and intervention for treatable inherited metabolic disorders (IMDs) presenting with global developmental delay and intellectual disabil‑ ity (collectively ‘treatable IDs’). Our aim is to update the 2012 review on treatable IDs and App to capture the advances made in the identifcation of new IMDs along with increased pathophysiological insights catalyzing therapeutic development and implementation. Methods: Two independent reviewers queried PubMed, OMIM and Orphanet databases to reassess all previously included disorders and therapies and to identify all reports on Treatable IDs published between 2012 and 2021. These were included if listed in the International Classifcation of IMDs (ICIMD) and presenting with ID as a major feature, and if published evidence for a therapeutic intervention improving ID primary and/or secondary outcomes is avail‑ able. Data on clinical symptoms, diagnostic testing, treatment strategies, efects on outcomes, and evidence levels were extracted and evaluated by the reviewers and external experts. The generated knowledge was translated into a diagnostic algorithm and updated version of the App with novel features. Results: Our review identifed 116 treatable IDs (139 genes), of which 44 newly identifed, belonging to 17 ICIMD categories.
    [Show full text]
  • Disorders Affecting Vitamin B6 Metabolism
    Received: 8 October 2018 Accepted: 12 December 2018 DOI: 10.1002/jimd.12060 REVIEW Disorders affecting vitamin B6 metabolism Matthew P. Wilson1 | Barbara Plecko2 | Philippa B. Mills1 | Peter T. Clayton1 1Genetics and Genomic Medicine, UCL GOS Institute of Child Health, London, UK Abstract 0 2Department of Pediatrics and Adolescent Vitamin B6 is present in our diet in many forms, however, only pyridoxal 5 -phosphate Medicine, Division of General Pediatrics, (PLP) can function as a cofactor for enzymes. The intestine absorbs nonphosphorylated University Childrens' Hospital Graz, B vitamers, which are converted by specific enzymes to the active PLP form. The role Medical University Graz, Graz, Austria 6 of PLP is enabled by its reactive aldehyde group. Pathways reliant on PLP include Correspondence amino acid and neurotransmitter metabolism, folate and 1-carbon metabolism, protein Philippa B. Mills, Genetics and Genomic and polyamine synthesis, carbohydrate and lipid metabolism, mitochondrial function Medicine, UCL GOS Institute of Child Health, 30 Guilford Street, London WC1N and erythropoiesis. Besides the role of PLP as a cofactor B6 vitamers also play other 1EH, UK. cellular roles, for example, as antioxidants, modifying expression and action of steroid Email: [email protected] Communicating Editor: Slyvia Stockler- hormone receptors, affecting immune function, as chaperones and as an antagonist of Ipsiroglu Adenosine-5'-triphosphate (ATP) at P2 purinoceptors. Because of the vital role of PLP in neurotransmitter metabolism, particularly synthesis of the inhibitory transmitter Funding information γ Schweizerischer Nationalfonds zur -aminobutyric acid, it is not surprising that various inborn errors leading to PLP defi- Förderung der wissenschaftlichen Forschung ciency manifest as B6-responsive epilepsy, usually of early onset.
    [Show full text]
  • Supplementary Informations SI2. Supplementary Table 1
    Supplementary Informations SI2. Supplementary Table 1. M9, soil, and rhizosphere media composition. LB in Compound Name Exchange Reaction LB in soil LBin M9 rhizosphere H2O EX_cpd00001_e0 -15 -15 -10 O2 EX_cpd00007_e0 -15 -15 -10 Phosphate EX_cpd00009_e0 -15 -15 -10 CO2 EX_cpd00011_e0 -15 -15 0 Ammonia EX_cpd00013_e0 -7.5 -7.5 -10 L-glutamate EX_cpd00023_e0 0 -0.0283302 0 D-glucose EX_cpd00027_e0 -0.61972444 -0.04098397 0 Mn2 EX_cpd00030_e0 -15 -15 -10 Glycine EX_cpd00033_e0 -0.0068175 -0.00693094 0 Zn2 EX_cpd00034_e0 -15 -15 -10 L-alanine EX_cpd00035_e0 -0.02780553 -0.00823049 0 Succinate EX_cpd00036_e0 -0.0056245 -0.12240603 0 L-lysine EX_cpd00039_e0 0 -10 0 L-aspartate EX_cpd00041_e0 0 -0.03205557 0 Sulfate EX_cpd00048_e0 -15 -15 -10 L-arginine EX_cpd00051_e0 -0.0068175 -0.00948672 0 L-serine EX_cpd00054_e0 0 -0.01004986 0 Cu2+ EX_cpd00058_e0 -15 -15 -10 Ca2+ EX_cpd00063_e0 -15 -100 -10 L-ornithine EX_cpd00064_e0 -0.0068175 -0.00831712 0 H+ EX_cpd00067_e0 -15 -15 -10 L-tyrosine EX_cpd00069_e0 -0.0068175 -0.00233919 0 Sucrose EX_cpd00076_e0 0 -0.02049199 0 L-cysteine EX_cpd00084_e0 -0.0068175 0 0 Cl- EX_cpd00099_e0 -15 -15 -10 Glycerol EX_cpd00100_e0 0 0 -10 Biotin EX_cpd00104_e0 -15 -15 0 D-ribose EX_cpd00105_e0 -0.01862144 0 0 L-leucine EX_cpd00107_e0 -0.03596182 -0.00303228 0 D-galactose EX_cpd00108_e0 -0.25290619 -0.18317325 0 L-histidine EX_cpd00119_e0 -0.0068175 -0.00506825 0 L-proline EX_cpd00129_e0 -0.01102953 0 0 L-malate EX_cpd00130_e0 -0.03649016 -0.79413596 0 D-mannose EX_cpd00138_e0 -0.2540567 -0.05436649 0 Co2 EX_cpd00149_e0
    [Show full text]